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Abstract
Background: Neonatal infection constitutes one of Senegal’s most important public health problems, with a
mortality rate of 41 deaths per 1,000 live births.
Methods: Between January 2007 and March 2008, 242 neonates with suspected infection were recruited at three
neonatal intensive care units in three major tertiary care centers in Dakar, the capital of Senegal. Neonatal infections were
confirmed by positive bacterial blood or cerebrospinal fluid culture. The microbiological pattern of neonatal infections
and the antibiotic susceptibility of the isolates were characterized. In addition, the genetic basis for antibiotic resistance
and the genetic background of third-generation cephalosporin-resistant (3GC-R) Enterobacteriaceae were studied.
Results: A bacteriological infection was confirmed in 36.4 % (88/242) of neonates: 22.7 % (30/132) during the early-onset
and 52.7 % (58/110) during the late-onset periods (p > 0.20). Group B streptococci accounted for 6.8 % of the 88 collected
bacterial isolates, while most of them were Enterobacteriaceae (n = 69, 78.4 %). Of these, 55/69 (79.7 %) were 3GC-R. The
blaCTX-M-15 allele, the blaSHV and the blaTEM were highly prevalent (63.5, 65.4 and 53.8 %, respectively), usually associated
with qnr genes (65.4 %). Clonally related strains of 3GC-R Klebsiella pneumoniae and 3GC-R Enterobacter cloacae, the two
most commonly recovered 3GC-R Enterobacteriaceae (48/55), were detected at the three hospitals, underlining the role
of cross-transmission in their spread. The overall case fatality rate was 18.6 %.
Conclusions: Measures should be taken to prevent nosocomial infections and the selection of resistant bacteria.
Keywords: Neonatal infections, Antimicrobial resistance, Third-generation cephalosporin-resistant Enterobacteriaceae,
CTX-M-15, Africa
Background
The fourth Millennium Development Goal, established
after the United Nations Millennium Summit in 2000,
seeks to decrease the mortality of children under five
years of age by two-thirds before 2015 [1]. Sub-Saharan
Africa has seen a rapid decline in its under-five mortality
rate, with the annual rate of reduction doubling between
1990–2000 and 2000–2013. However, progress in redu-
cing the neonatal mortality rate remains virtually stag-
nant in this part of the world. The number of neonatal
deaths has in fact increased in sub-Saharan Africa, from
944,000 in 1990 to 1,029,000 in 2013 [2].
Neonatal sepsis is defined as a clinical syndrome
occurring within the first 28 days of life, manifested by
systemic signs of infection, and isolation of a bacterial
pathogen from the bloodstream. Neonatal bloodstream
infection is associated with significant morbidity, poor
long-term outcomes, and a reported mortality rate of
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12–20 % [3, 4]. The early-onset period, defined as infection
within three days of birth (except for group B streptococci
(GBS), 0–6 days after birth), classically reflects vertically
transmitted infections. Late-onset infections are usually at-
tributed to bacteria acquired from the infant’s surroundings
(hospitals or community), Klebsiella spp. and Staphylococ-
cus aureus being the most frequently recovered [5]. Among
hospital born babies, most neonatal infections are hospital-
acquired (HA) in developing countries, irrespective of the
period of infection. Extended-spectrum beta-lactamase
(ESBL)-producing Klebsiella pneumoniae is the most fre-
quent HA pathogen [5], along with Staphylococcus aureus
and Escherichia coli [6]. Third-generation cephalosporins
(3GC) are commonly used as first-line treatment for neo-
natal infections in developing countries, resulting in a grad-
ual upward trend in the number of antibiotic resistant
isolates, especially among Enterobacteriaceae [5].
Senegal is a resource-limited country in equatorial Africa
(ranked 163/187 according to the Human Development
Index in 2013). Neonatal infection is one of Senegal’s most
important public health problems, with a neonatal mortal-
ity rate of 21 deaths per 1,000 live births in 2015 [7]. This
is four times the rate observed in developed countries [8].
Moreover, there is little data on bacterial resistance pat-
terns in neonatal infections in Senegal or in developing
countries [6].
We characterized the bacterial pathogens associated
with neonatal infection and their antibiotic susceptibility
patterns, in three major tertiary care centers; we also
studied the genetic basis for antibiotic resistance and the




From January 2007 to March 2008, neonates (≤28 days)
admitted to the neonatal intensive care units in the
Hôpital Principal de Dakar (HPD), Hôpital Aristide Le
Dantec (HALD) and Hôpital des Enfants Albert Royer
(HEAR), were consecutively pre-included if infection
was suspected according to the presence of at least two
of the following clinical signs: fever (temperature > 37.8 °C)
or hypothermia (temperature <35 °C), respiratory signs
(apnea, tachypnea (>60 breaths per minute), respira-
tory distress), neurological signs (hypotonia, weak re-
flexes, refusal to suck, perturbation of consciousness,
convulsions, coma, irritability), digestive signs (vomiting,
diarrhea), jaundice (early [<24 h after birth] or prolonged)
and cutaneous signs (purpura). One blood culture (stand-
ard volume 1–2 ml) was performed before starting anti-
biotic treatment for each neonate. A lumbar puncture was
prescribed except i) in severely ill infants with either car-
diovascular or respiratory distress, tense or bulbing anter-
ior fontanelle, the presence of severe thrombocytopenia,
or infection around the lumbosacral region [9], ii) in case
of parents or legal guardians’s refusal. Neonatal infection
was confirmed by a positive blood and/or cerebrospinal
fluid culture. Empirical antibiotic therapy was considered
inappropriate if the treatment regimen did not include at
least one antibiotic that was active in vitro against the in-
fecting microorganisms. The cause of death for patients
who died during hospitalization was recorded according
to the clinician’s assessment. Attributable mortality was
defined as neonatal death within three days after the onset
of infection.
Neonates were classified into two groups depending on
the age at the onset of clinical signs: early-onset period in
infants between zero and three days of age (except for
GBS, 0–6 days) and late-onset period in infants after three
days of age (except for GBS, >6 days).
Microbiological analysis, antimicrobial susceptibility
testing and detection of ESBL
Blood cultures (Hemoline performance diphasic medium,
bioMerieux, Marcy l'Etoile, France) were incubated aerob-
ically at 37 °C and observed daily during seven days. In
cases of visible microbial growth, blood and chocolate
agar plates (Biorad laboratories, Richmond, CA) were in-
oculated, incubated in a 5 % CO2 atmosphere at 37 °C,
and examined after 24 and 48 h. Cerebrospinal fluid (CSF)
were collected in sterile containers and processed within
2 h. Schaedler broth with vitamin K3, blood and chocolate
agar plates (Biorad laboratories, Richmond, CA) were in-
oculated, incubated at 37 °C in a 5 % CO2 atmosphere,
and examined after 24 and 48 h. API biochemical galleries
(API, bioMerieux, Marcy l’Etoile, France) were used for
bacterial identification. Growth of Bacillus, Corynebac-
terium, and Micrococcus species as well as coagulase-
negative staphylococci in the blood cultures was consid-
ered to be due to contaminants and these cultures were
excluded.
Antibacterial drug susceptibility was determined using
the disc diffusion method according to the guidelines of
the French Society of Microbiology. Production of ESBL
in 3GC-R Enterobacteriaceae was detected using the
double-disc synergy test [10].
DNA extraction and detection of beta-lactamase and
plasmid-mediated quinolone resistance genes
Previously described PCRs were used to screen for
carbapenem-hydrolyzing β-lactamase genes (blaVIM, blaIMP
and blaKPC), as well as plasmid-encoded blaCTX-M, blaAmpC,
blaSHV, blaTEM beta-lactamase genes, the aac(6′)-Ib
gene, and quinolone resistance qnrA/B/S and qepA
genes [11–13]. All aac(6′)-Ib positive strains were fur-
ther analyzed by digestion of the PCR product with
BtsCl (New England Biolabs, Ipswich, MA) to identify
the mutated aac(6’)-Ib-cr gene, which lacks the BtsCl
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restriction site present in the wild-type gene [14]. Isolates
resistant to cefoxitin were tested for the presence of six
families of the plasmid-borne ampC gene (FOX, ACC,
EBC, MOX, CIT, DHA) [15] and blaCMY-2.
Pulsed Field Gel Electrophoresis of Enterobacteriaceae
Escherichia coli, Klebsiella pneumoniae and Enterobacter
cloacae were analyzed by Pulsed Field Gel Electrophor-
esis (PFGE) as previously described [16].
Multilocus sequence typing of Group B streptococci
Group B streptococci (GBS) were studied by multilocus
sequence typing (MLST) using the MLST website for as-
signments [17].
Data analysis
Qualitative data were compared using the chi square
test and Student’s t test. P values lower than 0.05 were
considered to be significant. Statistical analysis was




Over the 15-month study period, 242 neonates with sus-
pected infection were consecutively included, among
whom 19 (7.9 %) were born at home: 119 (49.2 %) from
HPD, 86 (35.5 %) from HEAR and 37 (15.3 %) from
HALD. The sex ratio (M/F) was 1.4, the median age
3 days and median weight 2700 g; 54.5 % (132/242) were
in the early-onset period.
A bacteriological infection was confirmed in 36.4 %
(88/242) of the neonates (66 from HPD, 13 from HEAR
and 9 from HALD), among whom 36.4 % (32/88) were
premature; 22.7 % (95 % confidence interval (CI): 15.6–
29.8 %, 30/132) of those included during the early-onset
period and 52.7 % (95 % CI: 48.8–67.2 %, 58/110) of
those included during the late-onset period (p > 0.20).
The positivity rates of blood and CSF cultures were
34.1 % (77/226) and 68.8 % (11/16), respectively. All ne-
onates born at home (n = 9) were included during the
late-onset period. The median length of hospital stay
was 7 days (range 1–30 days).
Neonates presented the following clinical signs: fever
(n = 15, 17,0 %) or hypothermia (n = 20, 22,7 %); respira-
tory signs including respiratory distress (n = 30, 34,1 %),
tachypnea (n = 26, 29,5 %), apnoea (n = 4, 4,5 %); neuro-
logic signs including refusal to suck (n = 39, 44,3 %),
hypotonia (n = 29, 33,0 %), weak reflexes (n = 12, 13,6 %)
and perturbation of consciousness (n = 9, 10,2 %); digest-
ive signs including vomiting (n = 5, 5,7 %) and diarrhea
(n = 2, 2,3 %); jaundice (early (n = 18, 20,5 %), prolonged
(n = 7, 8,0 %)); purpura (n = 2, 2,3 %); cardiovascular col-
lapse (shock) (n = 3, 3,4 %). No significant difference was
found between neonates with sepsis and those with
meningitis (p > 0.20).
The outcome was known for 86 out of the 88 infected
neonates: 18.6 % (16/86) [10.4–26.8 % 95 % CI] died,
with no statistical difference (p = 0.39) between early-
onset (12/55, 21.8 %) and late-onset (4/31, 12.9 %). Le-
thality associated with sepsis was 17.3 % (13/75, 95 % CI:
8.7–25.9 %,), and that associated with meningitis, 27.3 %
(3/11, 95 % CI: 1–53.6 %).
Bacterial strains, antibiotic susceptibility and antibiotic
treatment
Among the 88 strains associated with neonatal infec-
tions, 69 (78.4 %) were Enterobacteriaceae, of which
66 were isolated from blood cultures (Table 1). Fifty-
five Enterobacteriaceae strains (79.7 %, 55/69) were
resistant to 3GC (33 K. pneumoniae, 15 E. cloacae, 4
E. coli, 2 Serratia liquefasciens and 1 E. aerogenes). All
3GC-R Enterobacteriaceae isolates were resistant to
all beta-lactams tested, except for cefoxitin (31.9 % re-
sistance, 22/69), and all were susceptible to imipenem.
In addition, Enterobacteriaceae isolates had high rates
of resistance to cotrimoxazole (79.8 %), gentamicin
(79.8 %), tobramycin (76.8 %), and ciprofloxacin
(66.7 %), a moderate rate of susceptibility to amikacin
(52.2 %), and a high rate of susceptibility to fosfomy-
cin (98.6 %).
The Gram-negative non-Enterobacteriaceae (5/88, 5.7 %)
were Pseudomonas aeruginosa (n = 4) and Acinetobacter
baumanii (n = 1). These isolates were collected from blood
(3/77, 3.9 %) and CSF (2/11, 18.2 %) cultures (Table 1).
One P. aeruginosa isolate was imipenem and levofloxa-
cin resistant whereas the A. baumanii isolate was resist-
ant to ceftazidime.
GBS was only isolated from 6.7 % (2/30) cases in
the early-onset and 6.9 % (4/58) cases in the late-
onset periods. GBS was found in 2.6 % (2/77) of posi-
tive blood cultures and 36.4 % (4/11) of positive CSF
cultures (Table 1). During the early-onset period, one
GBS infected case died with sepsis. All isolates were
ampicillin and erythromycin susceptible. Streptococcus
pneumoniae was isolated from CSF (2/11, 18.2 %);
both isolates were oxacillin susceptible. The two S.
pneumoniae infected cases died during the early-onset
period. Enterococcus faecalis/faecium (4/77, 5.2 %) and
Staphylococcus aureus (2/77, 2.6 %) were isolated from
blood during the late-onset period except for one S.
aureus (Table 1). Both S. aureus isolates were methicil-
lin susceptible.
The empirical antibiotic treatment consisted of a com-
bination of two or three antibiotics. The most frequently
prescribed antibiotics were gentamicin (100 %), 3GC
(78.8 %) and amoxicillin (31.8 %). The rate of inadequate
antibiotic treatment was 65.9 % (58/88), mainly due to
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Enterobacteriaceae resistant to both 3GC and gentami-
cin (79.7 %, 55/69).
Antibiotic resistance determinants in 3GC-resistant
(3GC-R) Enterobacteriaceae strains
All 3GC-R Enterobacteriaceae were tested for resistance
genes except for one E. aerogenes and two Serratia lique-
fasciens strains: 69.2 % (36/52) were positive for blaCTX-M
group 1 (n = 33) and group 8 (n = 3), 65.4 % (34/52) for
blaSHV, 53.8 % (28/52) for blaTEM and 3.8 % (2/52) for
ampC (CMY-2, DHA and CIT positives). All blaCTX-M
group 1 were assigned to the blaCTX-M-15 allele. The
aac(6’)-Ib gene was detected in 41 (78.8 %) of the 52 iso-
lates, of which 34 (82.9 %) were aac(6’)-Ib-cr. Of the 34
qnr-positive strains (65.4 %), 31 were qnrB, three were
qnrS, and qnrA and qepA were not detected (Table 2).
Pulsed-field Gel Electrophoresis of 3GC-R
Enterobacteriaceae
The 33 K. pneumoniae isolates grouped into five main
PFGE clusters (3 to 11 isolates) in Pulsed-field Gel
Electrophoresis (PFGE) analysis. The 15 E. cloacae iso-
lates yielded 10 distinct PFGE patterns, with six strains
belonging to a single cluster. These six isolates were
isolated in all the three hospitals. Each of the four
Escherichia coli isolates displayed a distinct PFGE pat-
tern (Table 2).
MLST of GBS
Five of the six isolates were investigated: ST17 was iso-
lated from two CSF samples from different hospitals,
and ST23 (n = 2) and ST26 (n = 1) from three blood
samples.
Table 2 Antibiotic resistance genes and Pulsed Field Gel Electrophoresis profiles of 52 E. coli, K. pneumoniae and Enterobacter
cloacae isolates resistant to third-generation cephalosporins
Bacteria species (N) blaTEM blaSHV blaCTX-M-15 blaCTX-M group 8 blaAmpC aac-(6)’-Ib-cr qnrB qnrS PFGE profiles
Klebsiella pneumoniae (33) 18 30 24 3 1 (CIT) 23 21 3 1 to 12
Enterobacter cloacae (15) 9 2 8 0 1 (CMY-2, DHA) 8 10 0 1 to 10
Escherichia coli (4) 1 2 1 0 0 3 3 0 1 to 4
PFGE Pulsed Field Gel Electrophoresis
Table 1 Distribution of 88 bacterial species by specimen (77 from blood and 11 from cerebrospinal fluid) isolated during the
neonatal period
Specimen Bacterial group Bacterial species Neonatal period
Early-onset period N Late-onset period N
Blood Enterobacteriaceae Klebsiella pneumoniae 15 24
Enterobacter cloacae 6 7
Enterobacter aerogenes 1 0
Escherichia coli 2 6
Cirobacter koseri 0 1
Serratia liquefacienx 1 1
Serratia marcescens 0 2
Gram-negative non-Enterobacteriaceae Pseudomonas aeruginosa 1 1
Acinetobacter baumanii 1 0
Gram-positive cocci Group B streptococci 2 0
Staphylococcus aureus 1 1
Enterococcus faecium 0 3
Enterococcus faecalis 0 1
Cerebrospinal fluid Enterobacteriacae Enterobacter cloacae 0 1
Escherichia coli 0 1
Morganella morganii 0 1
Gram-negative non-Enterobacteriaceae Pseudomonas aeruginosa 0 2
Gram-positive cocci Group B streptococci 0 4
Streptococcus pneumoniae 0 2
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Discussion
Blood culture remains the “gold standard” for the detec-
tion of neonatal sepsis, highlighting the importance of a
high index of suspicion based on clinical and laboratory
parameters long before the blood culture results are
known. Our study included 242 neonates with suspected
neonatal infections. The frequency of neonatal sepsis
(34.1 %, 77/226) was consistent with rates reported in
other African and Asian developing countries (34.8–
45.9 %) [18–20]. However, negative blood culture does
not rule out a bacterial infection, as obligate anaerobes
were not investigated in our study. In addition, coagulase-
negative staphylococci, Bacillus spp., Corynebacterium spp.
and Micrococcus spp. were excluded from this study due to
the lack of two successive blood cultures, but it is crucial to
recognize that they can also represent a true cause of late-
onset infection. A lumbar puncture was performed only in
16 neonates with suspected neonatal infection. Disruption
of African hospitals, combined with refusal by children’s
parents or legal guardians due probably to a cultural preex-
isting belief that this medical procedure will cause death
[21], lead to a probable underestimate of the true preva-
lence of meningitis in our studied population. The overall
lethality rate was 18.6 %. This value was in the range of re-
ported values in developing countries [5], including Senegal
(19.5 % in 1999) [22].
The pattern of pathogens associated with neonatal infec-
tions was quite different from that observed in developed
countries were GBS and E. coli are predominant [9]. GBS
and E. coli were responsible of 6.8 and 9.1 % of neonatal
infection in the current study, respectively. These data are
in the range of reported values in Sub-saharan Africa, 2–
8 % of cases for GBS and 5–16 % for E. coli [23]. The mi-
croorganisms most frequently recovered were Enterobacte-
riaceae (78.4 %), for both early and late-onset infections,
most of them being resistant to 3GC [5]. This indicates
that hospital environmental and human floras are reser-
voirs of ESBL-Enterobacteriaceae and are potential sources
of colonization and infection in newborns during delivery
and the post-natal period. The usual conditions prevailing
in hospital settings in low-income countries may favor
horizontal transmission of multiresistant bacteria [24].
They probably act as a barrier for GBS and E. coli trans-
mission, which could explain their low detection rates
among infected neonates. As a result, the majority of
early-onset infections may be more hospital acquired, than
vertically transmitted. Of note, pregnant women may rep-
resent a substantial source of multiresistant Enterobacteri-
aceae for vertical transmission to neonates as highlighted
by the high prevalence of ESBL-E among pregnant women
from Madagascar [24]. Further studies are needed to dif-
ferentiate maternally-acquired from hospital-acquired
routes of transmission to implement improved preventive
strategies in these settings.
Among Enterobacteriaceae, 79.8 % were 3GC-R, as
previously described in developing countries [5]. Then, a
significant proportion of the causal bacteria was not
treatable neither by the recommended first-line regimen
(ampicillin and gentamicin) [25] nor by alternative C3G
treatment. Thus, carbapenems are regarded as the ultim-
ate treatment option. However, these antimicrobials are
expensive and unaffordable for the vast majority of the
population in these settings, making these bacteria diffi-
cult to treat. In South-East Asia, many newborn babies
in hospitals are now treated with carbapenems as first-
line treatment for sepsis or suspected sepsis. However,
carbapenems should not be prescribed as empiric ther-
apy as highlighted by the emergence of resistant untreat-
able carbapenem-resistant Enterobacteriaceae infections
associated with high mortality in intensive care units
[26]. The alarming use of 3GC observed in our study,
contrary to recommendations of antibiotic use [25], has
contributed to selection pressure that has provided a
competitive advantage for C3G resistant strains. Quality-
assured basic microbiology services and routine bacterial
resistance surveillance are urgently needed in developing
countries in order to reduce antibiotic selection pressure
[27]. In addition, all necessary measures for preventing
hospital-acquired infections must be implemented.
These include standard hygiene practices, especially adher-
ence to hand hygiene policies, which are the cornerstone
for preventing the transmission of multidrug-resistant bac-
teria [27]. Indeed, cross-transmission plays a major role,
as suggested by the fact that neonates from the same de-
partment shared clonally related strains. This was true
for the K. pneumoniae and E. cloacae strains, which are
known to be highly transmissible in hospital settings,
especially in intensive care units [26]. In addition, blood
culture is time-consuming. Up to 6 days are usually re-
quired before antimicrobial susceptibility testing results
of bacterial pathogens are available. This delay often
causes an inappropriate empiric therapy but also a pro-
longed length of hospital stay, which favor the horizon-
tal transfer of multidrug resistant strains. Neonates in
different hospitals also shared clonally related strains
which suggests that there was cross-transmission events
between the three health care centers, probably by
transfer of infected or colonized patients.
3GC-R resistance in Enterobacteriaceae is mainly me-
diated by ESBL genes located on mobile genetic ele-
ments such as plasmids [28]. In our study conducted in
2007–2008, blaCTX-M group 1 or blaSHV was detected in
most of the strains (69.5 %), highlighting the blaTEM/
blaSHV to blaCTX-M-15 shift in the 2000s, observed in
Dakar [10, 29] and worldwide [30]. These genes were
frequently associated with qnr and aac(6’)-Ib-cr genes.
Frequent association of blaCTXM-15, qnrB and aac(6’)-Ib-cr
genes has been described in Enterobacteriaceae isolates
Breurec et al. BMC Infectious Diseases  (2016) 16:587 Page 5 of 7
in North, West, Central and East Africa, consistent
with the hypothesis that these resistance-determinant
genes are carried on the same plasmid [10, 29, 31].
Such an accumulation of resistance genes on a single
plasmid prone to horizontal transmission is problem-
atic, especially in countries with inadequate health care
systems. Early and appropriate antibiotic treatment is
the cornerstone of neonatal infection management [32].
This is of great concern, as 65.9 % of neonates did not
receive an appropriate empiric therapy in our study.
The emergence of carbapenemases, which has been de-
scribed in Senegal [33] but was not found in our study,
could be a serious challenge for infection control and
antibiotic therapy in the future.
In our study, there were only six cases of mother-to-
child transmission of GBS. Two isolates, both found in
infants with meningitis, were assigned to the ST17 hy-
pervirulent lineage. This ST is known to be associated
with neonatal disease and correlated with serotype III
[34, 35] which is predominant in meningitis or invasive
infections [34]. In 2007, a study conducted in Dakar on
healthy pregnant Senegalese women showed a GBS posi-
tive vaginal prevalence rate of 20 %. The three STs ob-
served in our study were all major clones in the previous
study; ST17, ST23 and ST26, representing 13.3, 14.7 and
20.0 %, respectively, of all GBS in cases of vaginal car-
riage [36]. Given the resources required for a screening-
based approach to guide intrapartum antibiotic prophy-
laxis, a risk factor-based approach with antibiotics pre-
scribed during labor for women showing risk factors of
early-onset GBS disease such as chorioamnionitis, pro-
longed rupture of membrane, or preterm delivery, [37] is
likely to be more applicable.
Conclusions
These data are of particular importance because of the
difficulty to carry out such studies in countries with
inadequate health care systems, and the lack of data
on pathogens associated with neonatal infections and
their antibiotic susceptibilities. 3GC-R Enterobacteria-
ceae were highly prevalent and GBS were detected. All
necessary measures should be taken in African hospi-
tals to prevent nosocomial infections and the selection
of resistant bacteria by implementing efficient nosoco-
mial infection surveillance programs. Standard hygiene
and especially hand hygiene policies need to be rein-
forced to prevent transmission of multidrug-resistant
bacteria.
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